Angiotensin converting enzyme DD genotype is associated with hypertensive crisis

Critical Care Medicine

Volumn 30, Issue 10, 2002, Pages 2236-2241

  Sunder Plassmann, Gere ^a   Kittler, Harald ^a   Eberle, Corinna ^a   Hirschl, Michael M ^a   Woisetschläger, Christian ^a   Derhaschnig, Ulla ^a   Laggner, Anton N ^a   Hörl, Walter H ^a   Födinger, Manuela ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Association study; Hypertensive emergency; Hypertensive urgency; Population genetics; Renin angiotensin aldosterone system

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; BETA 2 ADRENERGIC RECEPTOR; BINDING PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0036796877     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200210000-00010     Document Type: Article

References (62)

1. Tepel M, Zidek W: Hypertensive crisis: Pathophysiology, treatment and handling of complications. Kidney Int 1998; 53(Suppl 64): S2-S5
2. Bales A: Hypertensive crisis: How to tell if it's an emergency or an urgency. Postgrad Med 1999; 105:119-126, 130
3. Calhoun DA, Oparil S: Treatment of hypertensive crisis. N Engl J Med 1990; 323: 1177-1183
4. Zampaglione B, Pascale C, Marchisio M, et al: Hypertensive urgencies and emergencies: Prevalence and clinical presentation. Hypertension 1996; 27:144-147
5. Luft FC: Molecular genetics of human hypertension. J Hypertens 1998; 16:1871-1878
6. Luft FC: Molecular genetics of human hypertension. Curr Opin Nephrol Hypertens 2000; 9:259-266
7. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al: Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992; 71: 169-180
8. Bonnardeaux A, Davies E, Jeunemaitre X, et al: Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24:63-69
9. Masharani U, Frossard PM: MboI RFLP at the human renin (ren) gene locus. Nucleic Acids Res 1988; 16:2357
10. Knöll A, Schunkert H, Reichwald K, et al: Human renin binding protein: Complete genomic sequence and association of an intronic T/C polymorphism with the prorenin level in males. Hum Mol Genet 1997; 6:1527-1534
11. Cusi D, Barlassina C, Azzani T, et al: Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension (published erratum appears in Lancet 1997, 350: 524). Lancet 1997; 349:1353-1357
12. Reihsaus E, Innis M, MacIntyre N, et al: Mutations in the gene encoding for the β2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8:334-339
13. Rigat B, Hubert C, Alhenc-Gelas F, et al: An insertion/deletion polymorphism in the angiotensin 1-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346
14. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee: The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure (published erratum appears in Arch Intern Med 1998,158:573). Arch Intern Med 1997; 157:2413-2446
15. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. New York, Cold Spring Harbor Laboratory Press, 1989
16. Rigat B, Hubert C, Corvol P, et al: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20:1433
17. Marre M, Jeunemaitre X, Gallois Y, et al: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) Study Group. J Clin Invest 1997; 99:1585-1595
18. Russ AP, Maerz W, Ruzicka V, et al: Rapid detection of the hypertension-associated Met235→Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993; 2:609-610
19. Berge KE, Berg K: Polymorphisms at the angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) loci and normal blood pressure. Clin Genet 1998; 53:214-219
20. Martinez FD, Graves PE, Baldini M, et al: Association between genetic polymorphisms of the β2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100: 3184-3188
21. Frossard PM, Lestringant GG, Elshahat YI, et al: An MboI two-allele polymorphism may implicate the human renin gene in primary hypertension. Hypertens Res 1998; 21: 221-225
22. Sasieni PD: From genotypes to genes: Doubling the sample size. Biometrics 1997; 53: 1253-1261
23. Armitage P: Tests for linear trends in proportions and frequencies. Biometrics 1955; 11: 375-386
24. Schmidt S, Beige J, Walla-Friedel M, et al: A polymorphism in the gene for the angiotensin II type I receptor is not associated with hypertension. J Hypertens 1997; 15: 1385-1388
25. Timmermann B, Mo R, Luft FC, et al: β-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. Kidney Int 1998; 53:1455-1460
26. Tiret L, Rigat B, Visvikis S, et al: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205
27. Yu H, Bowden DW, Spray BJ, et al: Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans. J Am Soc Nephrol 1996; 7:2559-2564
28. Pontremoli R, Sofia A, Tirotta A, et al: The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension. J Am Soc Nephrol 1996; 7:2550-2558
29. O'Donnell CJ, Lindpaintner K, Larson MG, et al: Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998; 97: 1766-1772
30. Kunz R, Bork JP, Fritsche L, et al: Association between the angiotensin-converting enzyme-insertion/deletion: polymorphism and diabetic nephropathy: A methodologic appraisal and systematic review. J Am Soc Nephrol 1998; 9:1653-1663
31. Jeunemaitre X, Inoue I, Williams C, et al: Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997; 60: 1448-1460
32. Frimat L, Philippe C, Maghakian MN, et al: Polymorphism of angiotensin converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and end-stage renal failure in IgA Nephropathy: IGARAS - A study of 274 men. J Am Soc Nephrol 2000; 11: 2062-2067
33. Beige J, Zilch O, Hohenbleicher H, et al: Genetic variants of the renin-angiotensin system and ambulatory blood pressure in essential hypertension. J Hypertens 1997; 15: 503-508
34. Barlassina C, Citterio L, Bernardi L, et al: Genetics of renal mechanisms of primary hypertension: The role of adducin. J Hypertens 1997; 15:1567-1571
35. Glorioso N, Manunta P, Filigheddu F, et al: The role of α-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study. Hypertension 1999; 34: 649-654
36. Province MA, Arnett DK, Hunt SC, et al: Association between the α-adducin gene and hypertension in the HyperGEN Study. Am J Hypertens 2000; 13:710-718
37. Bray MS, Krushkal J, Li L, et al: Positional genomic analysis identifies the β2-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 2000; 101: 2877-2882
38. Kunz R, Kreutz R, Beige J, et al: Association between the angiotensinogen 235T-variant and essential hypertension in whites: A systematic review and methodological appraisal. Hypertension 1997; 30:1331-1337
39. Tiret L, Blanc H, Ruidavets JB, et al: Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: The PEGASE study. J Hypertens 1998; 16: 37-44
40. Födinger M, Hirschl MM, Schedler D, et al: Mutations in the carboxy terminus of the β and γ subunits of the epithelial sodium channel are not present in patients with hypertensive crisis. Eur J Clin Invest 1998; 28: 707-711
41. Födinger M, Schedler D, Fritsche-Polanz R, et al: Molecular analysis of the carboxy terminus of the beta and gamma subunits of the epithelial sodium channel in patients with end-stage renal disease. Nephron 1999; 81: 381-386
42. Födinger M, Fritsche-Polanz R, Schedler D, et al: Two novel mutations in the β subunit of the human epithelial sodium channel. Letter. Kidney Int 1999; 55:2530-2531
43. Siffert W, Rosskopf D, Siffert G, et al: Association of a human G-protein β3 subunit variant with hypertension. Nat Genet 1998; 18:45-48
44. Buchmayer H, Sunder-Plassmann G, Hirschl MM, et al: G-protein β3 subunit gene (GNB3) polymorphism 825C→T in patients with hypertensive crisis. Crit Care Med 2000; 28: 3203-3206
45. Matsusaka T, Hymes J, Ichikawa I: Angiotensin in progressive renal diseases: Theory and practice. J Am Soc Nephrol 1996; 7:2025-2043
46. Staessen JA, Wang JG, Ginocchio G, et al: The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15:1579-1592
47. Schunkert H: Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease. J Mol Med 1997; 75: 867-875
48. Candy G, Samani N, Norton G, et al: Association analysis of β2 adrenoceptor polymorphisms with hypertension in a Black African population. J Hypertens 2000; 18:167-172
49. Xie HG, Stein CM, Kim RB, et al: Human β2-adrenergic receptor polymorphisms: No association with essential hypertension in black or white Americans. Clin Pharmacol Ther 2000; 67:670-675
50. Schmitz C, Gotthardt M, Hinderlich S, et al: Normal blood pressure and plasma renin activity in mice lacking the renin-binding protein, a cellular renin inhibitor. J Biol Chem 2000; 275:15357-15362
51. Barlassina C, Norton GR, Samani NJ, et al: α-adducin polymorphism in hypertensives of South African ancestry. Am J Hypertens 2000; 13:719-723
52. Barlassina C, Schork NJ, Manunta P, et al: Synergistic effect of α-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion. Kidney Int 2000; 57:1083-1090
53. Kato N, Sugiyama T, Nabika T, et al: Lack of association between the α-adducin locus and essential hypertension in the Japanese population. Hypertension 1998; 31:730-733
54. Larson N, Hutchinson R, Boerwinkle E: Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension 2000; 35:1297-1300
55. Bray MS, Li L, Turner ST, Kardia SLR, et al: Association and linkage analysis of the α-adducin gene and blood pressure. Am J Hypertens 2000; 13:699-703
56. Ranade K, Hsuing AC, Wu KD, et al: Lack of evidence for an association between α-adducin and blood pressure regulation in Asian populations. Am J Hypertens 2000; 13: 704-709
57. Stefansson B, Ricksten A, Rymo L, et al: Angiotensin-converting enzyme gene I/D polymorphism in malignant hypertension. Blood Press 2000; 9:104-109
58. Ueda S, Meredith PA, Morton JJ, et al: ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans. Circulation 1998; 98:2148-2153
59. Baudin B: Angiotensin I-converting enzyme gene polymorphism and drug response. Clin Chem Lab Med 2000; 38:853-856
60. McNamara DM, Holubkov R, Janosko K, et al: Pharmacogenetic interactions between β-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. Circulation 2001; 103:1644-1648
61. Sasaki M, Oki T, Iuchi A, et al: Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies. J Hypertens 1996; 14:1403-1408
62. Ruggenenti P, Perna A, Zoccali C, et al: Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: Differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemiologici in Nefrologia (Gisen). J Am Soc Nephrol 2000; 11:88-96